Home > Search: Ranitidine Hydrochloride Injection

• Search Results

Search Results Get Your Free Credit Report Right Now! Zip Code: Join our discussion forums! Providers join our directory! General Topics A-Z Conditions Treatments Medications Fitness Nutrition Anatomy Travel/Destinations Other Topics From the West From the East

Main Topic Area Ranitidine Hydrochloride Injection All Topic Areas 1 - 10 of 1141  more >> Ranitidine Hydrochloride Injection Zantac Injection Ranitidine Zantac Zantac 75 Ranitidine Bismuth Citrate Tritec Ranitidine Oral Syrup Zantac Syrup Metoclopramide Hydrochloride Injection Articles 1 - 2 of 2 Statement on Generic Oxycodone Hydrochloride Extended Release Tablets The Food and Drug Administration today released the following statement on its approval of generic oxycodone hydrochloride extended-release tablets: Oxycodone hydrochloride extended-release products, such as OxyContin and its generic versions, are important options for the management of moderate-to-severe chronic pain, such as that associated with cancer and various other illnesses. FDA's approval of two generic oxycodone hydrochloride products should make this safe and effective medicine... U.S. Food and Drug Administration Antagon Injection Consumer Information Antagon is used to inhibit premature ovulation in women undergoing fertility procedures. Women who have experienced a hypersensitivity reaction to gonadotropin-releasing hormone (GnRH) or any other GnRH-type drug. Women who suspect or know they are pregnant. A physician specializing in fertility treatment should prescribe Antagon. Before starting treatment with Antagon, pregnancy must be ruled out. General Precautions with Antagon: Patients with hypersensitivity to GnRH should be closely... U.S. Food and Drug Administration News 1 - 5 of 331  more >> Actavis Receives Approval For Ranitidine Syrup In The U.S. MedicalNewsToday - Sat, 03 Mar 2007 08:00 EST FDA Approves Astellas' Vaprisol(R) For The Treatment Of Hypervolemic Hyponatremia MedicalNewsToday - Sat, 03 Mar 2007 08:00 EST Injection Drug Use Fueling Spread Of HIV In Mauritius MedicalNewsToday - Mon, 26 Feb 2007 09:00 EST International Narcotics Control Board Hindering HIV/AIDS Control Efforts, Should Be Independently Reviewed, Report Says MedicalNewsToday - Mon, 05 Mar 2007 12:00 EST More Frequent Participation In Needle-Exchange Programs Does Not Increase Risk Of HIV Infection, Study Says MedicalNewsToday - Fri, 02 Mar 2007 06:00 EST Clinical Trials 1 - 5 of 506  more >> TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer ClinicalTrials.gov Identifier: NCT00057720 - Active, not recruiting Ovarian Neoplasms A Pilot Randomized, Double-Blind, Placebo-Controlled, Parallel Design, Multicenter Trial to Evaluate the Effect of Ranitidine on Immunologic Indicators in Asymptomatic HIV-1 Infected Subjects With a CD4 Cell Count Between 400-700 Cells/mm3 ClinicalTrials.gov Identifier: NCT00002106 - Completed HIV Infections Long-Term Safety and Efficacy of Itopride Hydrochloride (HCl) in Patients Suffering from Functional Dyspepsia ClinicalTrials.gov Identifier: NCT00112203 - Active, not recruiting Dyspepsia Long-term Safety and Efficacy of Itopride Hydrochloride in Patients Suffering from Functional Dyspepsia ClinicalTrials.gov Identifier: NCT00110968 - Active, not recruiting Dyspepsia The Effect of Stomach Acid on Foscarnet ClinicalTrials.gov Identifier: NCT00000964 - Completed HIV Infections

GoldBambooTM Your Integrative Health and Wellness Resource November 29, 2009

email this page   |    print this page   |    bookmark this page   |    feedback on this page Page Updated: January 17, 2009

Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.